Abstract
Sleep apnea syndromes are disorders in which breathing repeatedly stops or grows shallow during sleep, fragmenting the night into hundreds of brief awakenings and starving the blood of oxygen. In the obstructive form the throat collapses despite continued effort to breathe; in the central form the brainstem briefly fails to command a breath at all. The interruptions are counted per hour as the apnea-hypopnea index, which grades severity. Beyond loud snoring and crushing daytime sleepiness, the condition erodes attention, memory, and executive control, and raises the long-term risk of stroke and cardiovascular disease. This article explains the types of sleep apnea, the mechanics of airway and brainstem failure, how severity is measured, and why the disorder matters so much for waking cognition, with a worked example and three interactive demonstrations.
Keywords: sleep apnea, hypopnea, cognitive impairment
What Sleep Apnea Syndromes Are
*Sleep apnea syndromes* are a family of disorders defined by the repeated interruption of breathing during sleep. An *apnea* is a complete pause in airflow lasting at least ten seconds; a *hypopnea* is a partial reduction in airflow deep enough to lower blood oxygen or provoke an awakening. In a person with the disorder these events recur dozens or even hundreds of times a night, each one nudging the brain briefly toward wakefulness so that sleep, though it may feel continuous, is in fact shattered into fragments. The clinical entity was first drawn together in the 1970s, when Guilleminault and his colleagues gathered the scattered observations of nocturnal breathing failure into a coherent set of *sleep apnea syndromes* (Guilleminault et al., 1976).
What unites these syndromes is the consequence rather than the cause. Whether the airway collapses mechanically or the brainstem fails to issue the command to breathe, the outcome is the same: intermittent drops in oxygen, surges of the stress response, and the repeated arousal of the sleeping brain. It is a strikingly common condition. Population studies begun in the 1990s found sleep-disordered breathing in a substantial fraction of middle-aged adults (Young et al., 1993), and later estimates, using more sensitive equipment and accounting for rising obesity, put the prevalence higher still (Peppard et al., 2013); a global analysis estimates that close to a billion adults worldwide have obstructive sleep apnea to some degree (Benjafield et al., 2019).
Key Takeaways
- Sleep apnea syndromes are disorders in which breathing repeatedly stops (apnea) or weakens (hypopnea) during sleep.
- The obstructive form is a mechanical collapse of the throat despite breathing effort; the central form is a failure of the brainstem to drive breathing.
- Severity is graded by the apnea-hypopnea index, the number of apneas and hypopneas per hour of sleep.
- The repeated arousals and drops in oxygen fragment sleep and impair attention, memory, and executive function by day.
- Untreated, the disorder raises the long-term risk of stroke, hypertension, and cardiovascular disease.
Figure 1
Airway Collapse and the Cycle of Desaturation
Types of Sleep Apnea Syndromes
In the vocabulary of *MeSH*, the National Library of Medicine's indexing system, Sleep Apnea Syndromes is the umbrella descriptor sitting beneath the broader headings *Apnea* and *Sleep Disorders, Intrinsic*. Directly beneath it are two child descriptors that carve the family by mechanism rather than by severity or symptom. The division is orthogonal to how bad the disorder is or how sleepy a patient feels: a mild and a severe case can share the same mechanism, and the same apnea-hypopnea index can arise from either type. It is also worth remembering that MeSH is a classification built for indexing the literature, not a theory of disease, so its branches mark where papers are filed as much as where nature draws its joints.
| Type | What defines it |
|---|---|
| Sleep Apnea, Obstructive | The upper airway collapses and blocks airflow even though the chest and diaphragm keep straining to breathe; effort continues but air does not move. It is by far the commoner type. |
| Sleep Apnea, Central | The brainstem transiently stops sending the signal to breathe, so effort and airflow cease together; the airway is open but no breath is attempted. |
A third, *mixed* pattern combines the two, typically beginning as a central pause and ending as an obstruction. Because the obstructive type accounts for the great majority of cases and carries most of the cognitive and cardiovascular burden, it dominates both the clinical literature and the sections that follow (Punjabi, 2008).
How the Airway and Brainstem Fail
The two types fail in mechanically opposite ways, and the difference is best seen in the relationship between effort and airflow. In *obstructive sleep apnea*, the muscles that hold the throat open relax during sleep, and in a vulnerable airway the soft tissues collapse inward; the chest and diaphragm heave against the blockage, so respiratory effort not only continues but intensifies, yet no air passes until an arousal restores muscle tone. In *central sleep apnea*, by contrast, the brainstem's rhythmic drive to breathe falters, and effort and airflow stop together, the chest lying still because no command has been sent. This contrast, effort-without-airflow versus no-effort-at-all, is what a sleep study uses to tell the two apart.
Demo 1 · Effort versus airflow
A sleep study tells the two types of apnea apart by comparing respiratory effort with actual airflow during an event. Choose a type and watch what happens in the shaded apnea in the middle of the window: in both, airflow stops, but the effort trace behaves in opposite ways.
Obstructive apnea is not simply a matter of anatomy. Modern work has shown that the disorder arises from several interacting traits, or *endotypes*: a narrow or collapsible airway is one, but so are a low *arousal threshold* that wakes the sleeper too readily, an unstable ventilatory control loop (*loop gain*) that overshoots and undershoots, and poor responsiveness of the airway-dilating muscles (Eckert et al., 2013). Different patients carry different combinations, which is why the disorder varies so much from person to person and why a single treatment does not suit everyone (Jordan et al., 2014). The daytime sleepiness that follows is likewise not a simple product of lost sleep time but of the repeated arousals and the intermittent oxygen deprivation acting together on the brain (Lal et al., 2021).
Measuring Severity: The Apnea-Hypopnea Index
Severity is quantified by the *apnea-hypopnea index (AHI)*, the average number of apneas and hypopneas recorded per hour of sleep during an overnight *polysomnography*. The index turns a night of irregular events into a single rate that clinicians use to classify the disorder and to gauge response to treatment. Its conventional thresholds are set out in Table 2.
| Category | AHI (events per hour) | Interpretation |
|---|---|---|
| Normal | Fewer than 5 | Breathing during sleep is essentially undisturbed. |
| Mild | 5 to under 15 | Disordered breathing is present and may cause symptoms in some people. |
| Moderate | 15 to under 30 | Sleep is substantially fragmented; daytime and cardiovascular effects become likely. |
| Severe | 30 or more | Breathing is disrupted every couple of minutes; the associated risks are greatest. |
Demo 2 · The apnea-hypopnea index
The apnea-hypopnea index is simply the total number of apneas and hypopneas divided by the hours of sleep. Set the counts recorded on an overnight study and the hours slept to see the index and the severity category it falls into. The starting values are the worked example from the article.
The AHI is the backbone of diagnosis, but it is an imperfect summary. Two people with the same index can differ in how deeply their oxygen falls, how long each event lasts, and how badly their sleep is fragmented, and these finer measures often track symptoms and consequences more closely than the raw count does (Gottlieb & Punjabi, 2020). The first-line treatment for moderate-to-severe disease is *continuous positive airway pressure (CPAP)*, a device that splints the airway open with a gentle stream of pressurized air, and the response to it is itself often assessed by the fall in AHI it produces.
Sleep Apnea and Cognition
The reason a breathing disorder belongs in cognitive psychology is that its daytime signature is cognitive. Fragmented sleep and intermittent oxygen deprivation together degrade the very functions that depend on restorative sleep. Meta-analyses of neuropsychological testing find that untreated patients perform worse than healthy sleepers across attention, vigilance, memory, and executive control, with the largest and most consistent deficits in sustained attention and executive function (Beebe et al., 2003; Bucks et al., 2013). Beebe and Gozal proposed an influential model to explain the pattern: the repeated hypoxia and sleep disruption fall especially heavily on the *prefrontal cortex*, whose functions of planning, inhibition, and working memory are precisely those most impaired (Beebe & Gozal, 2002).
Demo 3 · Fragmentation and the daytime cost
Sleep apnea harms thinking less by shortening sleep than by breaking it up. Raise the arousal index, the number of awakenings per hour, and watch a seven-hour night fracture into shorter and shorter runs, the longest stretch of deep sleep vanish, and an illustrative sustained-attention score fall with it.
Some of this damage has a visible anatomical counterpart. Neuroimaging has revealed structural changes in the brains of patients with severe obstructive sleep apnea, together with impaired memory and executive performance, and, encouragingly, both the deficits and some of the structural changes partly recover after months of treatment (Canessa et al., 2011). The stakes extend into later life. Sleep-disordered breathing in older adults is associated with an accelerated decline toward mild cognitive impairment and dementia (Osorio et al., 2015), and a systematic review across many cohorts found that people with sleep-disordered breathing were significantly more likely to develop cognitive impairment (Leng et al., 2017). Whether treatment can blunt that trajectory is an active question, and the largest trial of CPAP for neurocognitive outcomes found improvements in sleepiness but a more modest picture for cognition, underscoring how much remains unresolved (Kushida et al., 2012).
Worked Example: Reading a Sleep Study
Consider a patient who undergoes an overnight polysomnography. The technician records that the person slept for a total of seven hours, and that during that time the monitors captured 210 obstructive apneas and 105 hypopneas, with no central events. How severe is the disorder?
The apnea-hypopnea index is defined as the total number of apneas plus hypopneas divided by the hours of sleep. The events sum to 210 plus 105, which is 315 respiratory events. Dividing by the seven hours of recorded sleep gives 315 divided by 7, or 45 events per hour. Comparing this figure with the thresholds in Table 2, an index of 45 sits well above the cutoff of 30 that marks the severe category, so this patient has severe obstructive sleep apnea.
The number is worth pausing on. An index of 45 means the patient's breathing was interrupted, on average, once every eighty seconds across the whole night, and each interruption carried its own brief arousal and dip in oxygen. Even if the person spent seven hours in bed and believed they had slept through, their brain was pulled toward waking roughly 315 times, which is why the restorative depth of sleep is lost and why the daytime consequences for attention and memory are so pronounced. The arithmetic is trivial, but it converts a night of invisible events into the single number on which diagnosis and treatment turn.
Discussion
Sleep apnea syndromes sit at a crossroads of respiratory medicine, cardiology, and cognitive science, and each field sees a different face of the same disorder. To the pulmonologist it is a mechanical or neural failure of breathing; to the cardiologist it is a nightly stressor that drives hypertension and, over years, raises the risk of stroke and death (Yaggi et al., 2005), a risk that observational data suggest treatment can lower (Marin et al., 2005). To the cognitive scientist it is something rarer: a common, treatable condition that produces a reversible model of what chronic sleep fragmentation and intermittent hypoxia do to the human mind.
That last framing is what makes the disorder instructive. Because the deficits are measurable and, with treatment, partly reversible, sleep apnea offers a natural experiment on the dependence of daytime cognition on the integrity of sleep. It shows that it is not merely the hours spent asleep that matter but their continuity and the oxygen that accompanies them: a night broken into hundreds of fragments, even if long, cannot do the work that consolidated sleep does. The concentration of deficits in attention and executive function, and their link to prefrontal vulnerability, has made the disorder a recurring test case for theories of how sleep supports higher cognition (Beebe & Gozal, 2002).
Current Directions
Two questions dominate current research. The first is whether treating sleep apnea can protect the aging brain. The epidemiological link between sleep-disordered breathing and later cognitive decline is now well established (Leng et al., 2017; Osorio et al., 2015), but establishing that treatment alters the trajectory has proven harder, in part because adherence to CPAP is difficult and trials must run for years to detect a change in dementia risk. The mixed cognitive results of large treatment trials have pushed the field toward better outcome measures and toward identifying which patients stand to benefit most (Kushida et al., 2012).
The second is the move toward *precision* treatment built on the endotype framework. If a given patient's disorder is driven mainly by a low arousal threshold or an unstable control loop rather than by a purely collapsible airway, then therapies aimed at those specific traits, rather than pressurized air alone, may help (Eckert et al., 2013). Alongside this, ultrasensitive home monitoring and new measures that capture the depth and duration of events, not just their count, promise to refine the crude summary the apnea-hypopnea index provides and to connect the physiology of the night more tightly to its daytime cost (Gottlieb & Punjabi, 2020).
Common Misconceptions
- Sleep apnea is just heavy snoring.
- Snoring is a common sign, but the disorder is defined by repeated apneas and hypopneas that fragment sleep and lower blood oxygen; many loud snorers do not have apnea, and some patients with apnea barely snore (Guilleminault et al., 1976).
- It only affects people who are overweight.
- Excess weight is a major risk factor, but the disorder also arises from craniofacial structure, a low arousal threshold, unstable respiratory control, and other traits, so people of normal weight can be affected too (Eckert et al., 2013).
- All sleep apnea is a blocked airway.
- That describes the obstructive type; in central sleep apnea the airway is open and the brainstem simply fails to command a breath, so effort and airflow cease together (Punjabi, 2008).
- Enough hours in bed make apnea harmless to thinking.
- Time in bed is not the issue; the repeated arousals and oxygen dips fragment sleep and impair attention, memory, and executive function even when total sleep time looks adequate (Beebe et al., 2003).
Glossary
- Apnea-hypopnea index (AHI).
- The average number of apneas and hypopneas per hour of sleep, used to grade the severity of sleep apnea.
- Apnea.
- A complete pause in airflow during sleep lasting at least ten seconds.
- Arousal threshold.
- The ease with which a respiratory disturbance wakes a sleeper; a low threshold, which wakes the person too readily, is one of the traits that can drive obstructive apnea.
- Central sleep apnea.
- The form in which the brainstem transiently stops driving breathing, so respiratory effort and airflow cease together while the airway stays open.
- Continuous positive airway pressure (CPAP).
- The first-line treatment for moderate-to-severe obstructive apnea, a device that splints the airway open with a gentle stream of pressurized air.
- Endotype.
- One of the underlying physiological traits, such as airway collapsibility or loop gain, that combine to produce obstructive sleep apnea in a given person.
- Hypopnea.
- A partial reduction in airflow during sleep that is deep enough to lower blood oxygen or provoke an arousal.
- Intermittent hypoxia.
- The repeated falls and recoveries of blood oxygen produced by successive apneas, thought to contribute to cognitive and cardiovascular harm.
- Loop gain.
- A measure of the stability of the respiratory control system; high loop gain overshoots and undershoots, destabilizing breathing during sleep.
- Obstructive sleep apnea.
- The common form in which the upper airway collapses and blocks airflow despite continued effort to breathe.
- Polysomnography.
- The overnight sleep study that records breathing, oxygen, brain waves, and movement to detect and count respiratory events.
- Prefrontal cortex.
- The frontal brain region supporting planning, inhibition, and working memory, proposed to be especially vulnerable to the hypoxia and fragmentation of sleep apnea.
- Sleep fragmentation.
- The breaking of sleep into short pieces by repeated arousals, which prevents the restorative depth of sleep even when total time asleep is long.
- Snoring.
- The sound of turbulent airflow through a partially narrowed upper airway, a common but non-specific sign of obstructive sleep apnea.
Key Researchers
Danny J. Eckert
A respiratory physiologist at Flinders University who defined the phenotypic, or endotype, causes of obstructive sleep apnea beyond anatomy, identifying arousal threshold, loop gain, and muscle responsiveness as therapeutic targets.
ORCID - Faculty page
David Gozal
A pediatric sleep researcher at Marshall University who built the prefrontal-cortex model linking nocturnal upper-airway obstruction to daytime cognitive and behavioral deficits.
ORCID - Faculty page
Christian Guilleminault
(1938-2019). The sleep-medicine pioneer at Stanford University who coined the term obstructive sleep apnea syndrome and, with Dement, first drew the sleep apnea syndromes together as a clinical entity in 1976.
Wikipedia - Wikidata
Atul Malhotra
A pulmonary and sleep physician-scientist at the University of California, San Diego who studies the upper-airway pathophysiology of obstructive sleep apnea and led the analysis estimating its global prevalence.
Wikipedia - Wikidata
Naresh M. Punjabi
A physician-scientist at the University of Miami who mapped the epidemiology of obstructive sleep apnea and its metabolic and cardiovascular consequences.
ORCID - Faculty page
Colin E. Sullivan
A physician at the University of Sydney who invented nasal continuous positive airway pressure in 1981, the treatment that transformed the management of obstructive sleep apnea.
Wikipedia - Faculty page
Terry Young
An epidemiologist at the University of Wisconsin-Madison who initiated and led the Wisconsin Sleep Cohort Study, the population sample that established the prevalence of sleep-disordered breathing in middle-aged adults.
Faculty page
Frequently Asked Questions
What is sleep apnea?
It is a disorder in which breathing repeatedly stops or becomes shallow during sleep, with each event lasting at least ten seconds and recurring many times an hour, fragmenting sleep and lowering blood oxygen (Guilleminault et al., 1976).
What is the difference between obstructive and central sleep apnea?
In obstructive apnea the airway collapses while the chest keeps straining to breathe; in central apnea the brainstem stops sending the signal to breathe, so effort and airflow cease together and the airway stays open (Punjabi, 2008).
How is the severity of sleep apnea measured?
By the apnea-hypopnea index, the number of apneas and hypopneas per hour of sleep: fewer than 5 is normal, 5 to 15 is mild, 15 to 30 is moderate, and 30 or more is severe (Gottlieb & Punjabi, 2020).
How common is sleep apnea?
It is very common. Population studies found sleep-disordered breathing in a large share of middle-aged adults, and a global estimate suggests close to a billion people have obstructive sleep apnea to some degree (Benjafield et al., 2019).
How does sleep apnea affect thinking and memory?
The repeated arousals and oxygen dips impair attention, vigilance, memory, and executive function, with the heaviest toll on sustained attention and on the planning and inhibition supported by the prefrontal cortex (Beebe & Gozal, 2002; Bucks et al., 2013).
Can treating sleep apnea reverse the cognitive effects?
Treatment often improves daytime sleepiness, and some cognitive deficits and even structural brain changes partly recover after months of therapy, though the degree of cognitive recovery varies and remains under study (Canessa et al., 2011; Kushida et al., 2012).
Does sleep apnea increase the risk of other diseases?
Yes. Untreated obstructive sleep apnea raises the long-term risk of hypertension, stroke, and cardiovascular death, and observational data suggest that treatment can lower that risk (Yaggi et al., 2005; Marin et al., 2005).
Is sleep apnea linked to dementia?
Sleep-disordered breathing in older adults is associated with faster cognitive decline and a higher likelihood of developing cognitive impairment, though whether treatment prevents dementia is not yet settled (Osorio et al., 2015; Leng et al., 2017).
References
Guilleminault, C., Tilkian, A., & Dement, W. C. (1976). The sleep apnea syndromes. Annual Review of Medicine, 27, 465-484. https://doi.org/10.1146/annurev.me.27.020176.002341
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. New England Journal of Medicine, 328(17), 1230-1235. https://doi.org/10.1056/NEJM199304293281704
Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013). Increased prevalence of sleep-disordered breathing in adults. American Journal of Epidemiology, 177(9), 1006-1014. https://doi.org/10.1093/aje/kws342
Benjafield, A. V., Ayas, N. T., Eastwood, P. R., Heinzer, R., Ip, M. S. M., Morrell, M. J., Nunez, C. M., Patel, S. R., Penzel, T., Pepin, J. L., Peppard, P. E., Sinha, S., Tufik, S., Valentine, K., & Malhotra, A. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis. The Lancet Respiratory Medicine, 7(8), 687-698. https://doi.org/10.1016/S2213-2600(19)30198-5
Punjabi, N. M. (2008). The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society, 5(2), 136-143. https://doi.org/10.1513/pats.200709-155MG
Eckert, D. J., White, D. P., Jordan, A. S., Malhotra, A., & Wellman, A. (2013). Defining phenotypic causes of obstructive sleep apnea: Identification of novel therapeutic targets. American Journal of Respiratory and Critical Care Medicine, 188(8), 996-1004. https://doi.org/10.1164/rccm.201303-0448OC
Jordan, A. S., McSharry, D. G., & Malhotra, A. (2014). Adult obstructive sleep apnoea. The Lancet, 383(9918), 736-747. https://doi.org/10.1016/S0140-6736(13)60734-5
Lal, C., Weaver, T. E., Bae, C. J., & Strohl, K. P. (2021). Excessive daytime sleepiness in obstructive sleep apnea: Mechanisms and clinical management. Annals of the American Thoracic Society, 18(5), 757-768. https://doi.org/10.1513/AnnalsATS.202006-696FR
Gottlieb, D. J., & Punjabi, N. M. (2020). Diagnosis and management of obstructive sleep apnea: A review. JAMA, 323(14), 1389-1400. https://doi.org/10.1001/jama.2020.3514
Beebe, D. W., Groesz, L., Wells, C., Nichols, A., & McGee, K. (2003). The neuropsychological effects of obstructive sleep apnea: A meta-analysis of norm-referenced and case-controlled data. Sleep, 26(3), 298-307. https://doi.org/10.1093/sleep/26.3.298
Bucks, R. S., Olaithe, M., & Eastwood, P. (2013). Neurocognitive function in obstructive sleep apnoea: A meta-review. Respirology, 18(1), 61-70. https://doi.org/10.1111/j.1440-1843.2012.02255.x
Beebe, D. W., & Gozal, D. (2002). Obstructive sleep apnea and the prefrontal cortex: Towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. Journal of Sleep Research, 11(1), 1-16. https://doi.org/10.1046/j.1365-2869.2002.00289.x
Canessa, N., Castronovo, V., Cappa, S. F., Aloia, M. S., Marelli, S., Falini, A., Alemanno, F., & Ferini-Strambi, L. (2011). Obstructive sleep apnea: Brain structural changes and neurocognitive function before and after treatment. American Journal of Respiratory and Critical Care Medicine, 183(10), 1419-1426. https://doi.org/10.1164/rccm.201005-0693OC
Osorio, R. S., Gumb, T., Pirraglia, E., Varga, A. W., Lu, S. E., Lim, J., Wohlleber, M. E., Ducca, E. L., Koushyk, V., Glodzik, L., Mosconi, L., Ayappa, I., Rapoport, D. M., & de Leon, M. J. (2015). Sleep-disordered breathing advances cognitive decline in the elderly. Neurology, 84(19), 1964-1971. https://doi.org/10.1212/WNL.0000000000001566
Leng, Y., McEvoy, C. T., Allen, I. E., & Yaffe, K. (2017). Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: A systematic review and meta-analysis. JAMA Neurology, 74(10), 1237-1245. https://doi.org/10.1001/jamaneurol.2017.2180
Kushida, C. A., Nichols, D. A., Holmes, T. H., Quan, S. F., Walsh, J. K., Gottlieb, D. J., Simon, R. D., Guilleminault, C., White, D. P., Goodwin, J. L., Schweitzer, P. K., Leary, E. B., Hyde, P. R., Hirshkowitz, M., Green, S., McEvoy, L. K., Chan, C., Gevins, A., Kay, G. G., ... Dement, W. C. (2012). Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep, 35(12), 1593-1602. https://doi.org/10.5665/sleep.2226
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005). Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine, 353(19), 2034-2041. https://doi.org/10.1056/NEJMoa043104
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. N. (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. The Lancet, 365(9464), 1046-1053. https://doi.org/10.1016/S0140-6736(05)71141-7